Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Sarah_Boyce
|
| gptkbp:clinicalFocus |
gptkb:myotonic_dystrophy_type_1
gptkb:Duchenne_muscular_dystrophy gptkb:facioscapulohumeral_muscular_dystrophy rare muscle diseases |
| gptkbp:focus |
RNA therapeutics
antibody oligonucleotide conjugates |
| gptkbp:foundedYear |
2012
|
| gptkbp:founder |
gptkb:Art_Levin
|
| gptkbp:headquartersLocation |
gptkb:La_Jolla,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Avidity Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:AOC_1001
gptkb:AOC_1020 gptkb:AOC_1044 |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:gene
|
| gptkbp:website |
https://aviditybiosciences.com/
|
| gptkbp:bfsParent |
gptkb:Fine_Structure_Ventures
gptkb:Nessan_Bermingham |
| gptkbp:bfsLayer |
7
|